S&P ASX All Technology

US Dollar vs AUD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

TERN Terns Pharmaceuticals Inc

5.01

-0.09 (-1.76%)

01 May 2024 - Closed

Delayed by 15 minutes

Terns Pharma gains 9% on positive TERN-101 data in mid-stage NASH study

To read the full story on Seeking Alpha, click here.

Terns Pharmaceuticals (NASDAQ:TERN)
Historical Stock Chart
From Apr 2024 to May 2024

Click Here for more Terns Pharmaceuticals Charts.

Terns Pharmaceuticals (NASDAQ:TERN)
Historical Stock Chart
From May 2023 to May 2024

Click Here for more Terns Pharmaceuticals Charts.

Terns Pharmaceuticals Inc News

Terns Pharmaceuticals Announces Data from Ongoing Phase 1 Pharmacokinetic Study of Allosteric BCR-ABL Inhibitor TERN-701 in Adult Healthy Volunteers and Highlights Potential for Competitive Differentiation
Tuesday 30 April 2024 (1 day ago) • GlobeNewswire Inc.

Terns Pharmaceuticals Appoints Melita Sun Jung as Chief Business Officer
Thursday 11 April 2024 (3 weeks ago) • GlobeNewswire Inc.

Terns Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Updates
Friday 15 March 2024 (2 months ago) • GlobeNewswire Inc.

Terns Pharmaceuticals Announces Orphan Drug Designation Granted to TERN-701 for the Treatment of Chronic Myeloid Leukemia
Tuesday 12 March 2024 (2 months ago) • GlobeNewswire Inc.

Terns Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(C)(4)
Friday 8 March 2024 (2 months ago) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 6 March 2024 (2 months ago) • Edgar (US Regulatory)

Terns Pharmaceuticals to Participate in Upcoming March Investor Conferences
Wednesday 28 February 2024 (2 months ago) • GlobeNewswire Inc.

Form 3 - Initial statement of beneficial ownership of securities
Friday 16 February 2024 (2 months ago) • Edgar (US Regulatory)

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Thursday 15 February 2024 (3 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 8 February 2024 (3 months ago) • Edgar (US Regulatory)

Terns Pharmaceuticals Reports Inducement Grants to New Chief Executive Officer Under Nasdaq Listing Rule 5635(C)(4)
Thursday 8 February 2024 (3 months ago) • GlobeNewswire Inc.

Terns Pharmaceuticals Appoints Amy Burroughs as Chief Executive Officer
Thursday 8 February 2024 (3 months ago) • GlobeNewswire Inc.

More Terns Pharmaceuticals Inc News Articles

Woodside Petroleum

AUD vs US Dollar

Australia And New Zealan...

Commonwealth Bank Of Aus...

Australian SE All Ordina...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions